β-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?

Neuroscience Letters

Volumn 55, Issue 2, 1985, Pages 179-184

  Collins, Michael A ^a   Neafsey, Edward J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

alkaloids; MPTP; N methyl 4 phenyl 1,2,5,6 tetrahydropyridine; owl monkeys; parkinsonism; tetrahydro carbolines; carbolines

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; BETA CARBOLINE; LEVODOPA; NEUROTOXIN; SEROTONIN;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CENTRAL NERVOUS SYSTEM; DRUG COMPARISON; DRUG SCREENING; ETIOLOGY; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NERVOUS SYSTEM; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; TETRAHYDROHARMAN; THERAPY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL; AOTUS TRIVIRGATUS; CARBOLINES; CAUDATE NUCLEUS; COMPARATIVE STUDY; DOPAMINE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; INDOLES; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PYRIDINES; SEROTONIN; SUBSTANTIA NIGRA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021992979     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(85)90016-3     Document Type: Article

References (23)

1. Beta-carbolines, psychoactive compounds in the mammalian body
2. Etiology of Parkinson's disease: a research strategy
3. Identification and quantitation of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland
4. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey; concentrations and in vivo synthesis rates
5. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine
6. Aetiology of Parkinson's disease
7. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
8. Selective neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in subhuman primates and man: a new animal model of Parkinson's disease
9. Mammalian alkaloids
10. A further insight into the metabolism of certain beta-carbolines
11. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
12. Urinary metabolites of tetrahydronorharmane in the rat
13. Stress elevation of brain and adrenal levels of non-polar tryptophan metabolites
14. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
15. Metabolism of 6-methoxy tetrahydro-beta-carboline in rats
16. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
17. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the squirrel monkey
18. Pargyline prevents MPTP-induced parkinsonism in primates
19. +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra
20. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
21. 2-Methyl-tetrahydro-beta-carboline, a potential ‘MPTP-like’ agent: striatal dopaminergic toxicity in mice
22. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain